Michael Gelband’s Solventum SOLV Stock Holding History

Michael Gelband’s Portfolio SOLV Stock Details SOLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-163,837	Closed	-$10.7M	–	2164
2026 Q1	$10.7M	Buy	163,837 +86,476	+112%	+$6.42M	0.09%	218
2025 Q4	$6.13M	Sell	77,361 -14,385	-16%	-$1.1M	0.05%	402
2025 Q3	$6.7M	Buy	+91,746	New	+$6.73M	0.07%	310
2024 Q2	–	Sell	-16,340	Closed	-$1.14M	–	2066
2024 Q1	$1.14M	Buy	+16,340	New	+$1.22M	0.01%	904

Other funds holding SOLV

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TFM

Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Michael Gelband's SOLV Position: Q2 2026 in Review

Michael Gelband sold out of Solventum (SOLV) in Q2 2026, closing a stake of 163,837 shares — an estimated $10.7M sold.

Michael Gelband first reported a position in SOLV in Q1 2024 and held it in 4 quarters. The position peaked at $10.7M in Q1 2026. 873 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

Michael Gelband reported no remaining Solventum position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 163,837 Solventum shares in Q2 2026, an estimated $10.7M.
Michael Gelband first reported a position in Solventum in Q1 2024 and held it in 4 quarters.
Michael Gelband's Solventum position peaked at $10.7M in Q1 2026.
873 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.